MannKind Corp (NASDAQ:MNKD)

biotech

Companies Betting on the Next 10 Blockbuster Drugs

The biotech sector has seen its valuations hit hard in many cases in 2014, but many investors remain excited about the future wave of big biotech drugs -- and big ...
Read Full Story »
Food and Drug Administration logo

FDA Keeps Driving Up Future Cost of Inhalable Insulin

MannKind Corp. (NASDAQ: MNKD) is suffering another setback from the U.S. Food & Drug Administration. While the FDA has been far from a friend to MannKind over the past few ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Rescued the Rally for One More Day

April 2, 2014: Markets opened mixed on Wednesday following in the ADP payroll data and n increase in factory orders reported early in the day. Mortgage applications were down again ...
Read Full Story »
76764023

Can MannKind Shares Double Again on FDA Approval? (Final)

MannKind Corp. (NASDAQ: MNKD) has a serious victory within its grasp. The company has struggled to get its Afrezza inhalable insulin to market for years, and that dream now seems ...
Read Full Story »
153576724

Vindication for MannKind With FDA Panel Backing

MannKind Corp. (NASDAQ: MNKD)had been trading as though the stock was bracing for an U.S. Food and Drug Administration (FDA) panel decision recommending against the approval of its inhalable insulin ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: BlackBerry, ING, Lululemon, MannKind, Vipshop and More

Stocks are again wanting to challenge new highs, yet investors remain anxious. They want upside from the bull market but do not want to buy the top or get stuck ...
Read Full Story »
76764023

Volatility and Options in MannKind Shaking Speculators Out

MannKind Corp. (NASDAQ: MNKD) is a stock that has been on a wild ride for many years. The company's inhalable insulin has been held up from being approved for years ...
Read Full Story »
170622870

Scorching Hot Biotech Tape: Small-Cap and Mid-Cap Stocks on Fire

The start of 2014 for the small and mid-cap biopharma group has been torrid. Positive exciting catalysts delivering greater-than-expected (or even in-line) results have rapidly pushed selected names higher. The ...
Read Full Story »
145922793

Is Inhalable Insulin Assured To Be Approved By The FDA?

If you have followed the diabetes drug market for very long, chances are high that you have run across the possibility of an inhalable form of insulin ultimately being approved ...
Read Full Story »
Bull and Bear

Top Analyst Downgrades and Stocks to Sell: Buckeye, MannKind, VistaPrint and More

Interest rates have risen and volatility in stocks has resumed. Traders and investors are looking for bargain stocks but also trying to decide which stocks they should get out as ...
Read Full Story »
Bull and Bear figures

Closing Bell for Friday on Wall Street: Markets Open Lower, Wobble to Weak Close

August 16, 2013: U.S. equity markets opened lower this morning following big down day on Thursday. In the U.S., the Census Bureau’s report on July housing starts put up a ...
Read Full Story »
Bull and Bear

Top Analyst Downgrades and Stocks to Sell: Bank of America, J.P. Morgan, Intel, Sprint, More

Investors frequently get to see the analyst upgrades and Buy ratings from Wall Street firms. What investors often do not get to see is when analyst downgrade stocks to sell ...
Read Full Story »
Bull and Bear figures

Closing Bell for Friday on Wall Street: Markets Open Lower, Fail to Break Out

U.S. equity markets opened sharply lower again this morning, but this time reacting to yesterday’s comments by Fed Chairman Ben Bernanke that the Fed could slow its bond purchases in ...
Read Full Story »
Bull and Bear figures

Closing Bell for Thursday on Wall Street: Markets Stall on Japan Losses

U.S. equity markets opened sharply lower this morning, taking a lead from Japan’s Nikkei, which fell more than 7% for the day. Japan’s government bond yields spiked until the Bank ...
Read Full Story »
Bull and Bear figures

Closing Bell for Wednesday on Wall Street: Markets Blunted on Fed Comments, Minutes

U.S. equity markets opened barely higher this morning following a report that mortgage loan applications had fallen by 9.8% from the previous week, on top of a 7% decline for ...
Read Full Story »